How It Works
Life’s not always easy – especially on your skin. You’ve earned each and every one of those wrinkles. Late nights, long golf outings, and kids all impact the appearance of your skin. And getting older doesn’t help either. Aging skin loses natural support structures (collagen and elastin) that keep skin supple and youthful. As the years go by, the support structures of the skin diminish, and the skin loses its ability to bounce back. Wrinkles and creases are the unfortunate result.
But now there’s a way to hide the years of misuse and abuse on the skin. Injectable fillers are used to plump the skin and erase evidence of a well-lived life. Wrinkle fillers are a minimally invasive procedure that your healthcare provider can administer in-office, over a lunch hour. Using a fine gauge needle, your healthcare provider will inject the filler under the skin, to rejuvenate your tired skin instantly! RADIESSE® Volumizing Filler is an ideal choice to do just that. Not only does it provide immediate volume, but RADIESSE Volumizing Filler also stimulates the production of your own natural collagen.1 Only RADIESSE Volumizing Filler works in such a way that it can immediately fix facial wrinkles, and continue to provide structure over time, with results that last a year or more in many patients.2,3
Ideal for a Man’s Rugged Skin
Made from an exclusive, natural mineral, RADIESSE Volumizing Filler is injected through a fine needle and placed under the skin. Immediately, the filler works to add volume under the skin and instantly hide the signs of wrinkles and creases. Over time, as the mineral begins to break down, the benefits of RADIESSE Volumizing Filler continue as your own natural collagen is stimulated, providing additional structure after the initial effects of RADIESSE Volumizing Filler have diminished.1 The treatment’s results are both immediate and long-lasting, providing wrinkle relief for up to a year or more in many patients.2,3 The incredible lifting capacity of this exclusive, natural mineral makes RADIESSE Volumizing Filler perfect for smoothing wrinkles and folds of a man’s rugged skin.
Mechanism of Action
RADIESSE® Volumizing Filler is composed of Calcium Hydroxylapatite (CaHA) microspheres suspended in an aqueous gel carrier.1
Once injected, it provides immediate volume and correction but continues to work by stimulating the body to produce its own natural collagen.1
Over time, the gel is absorbed and the body metabolizes the CaHA microspheres leaving behind only your own natural collagen.1
Why choose RADIESSE® Volumizing Filler?
- It is the only injectable filler that immediately replenishes lost volume and stimulates the production of your own natural collagen1
- It is clinically proven to last a year or more in many patients2,3
- RADIESSE patients are significantly more satisfied than patients treated with other leading wrinkle fillers2,4
- It is FDA approved to mix with lidocaine to significantly reduce injection-related pain
Treatment with RADIESSE Volumizing Filler is quick, comfortable, and convenient, with immediately visible, long-lasting results.2,3 Ask your healthcare provider about long-lasting, wrinkle-free correction with RADIESSE Volumizing Filler, today.2,3
To discover what RADIESSE Volumizing Filler can do for you, find a provider in your area.
1. Berlin AL, Hussain M, Goldberg DJ. Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis. Dermatol Surg. 2008;34:S64-S67.
2. Moers-Carpi M, Vogt S, Santos BM, et al. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. Dermatol Surg. 2007;33:S144-S151.
3. Bass LS, Smith S, Busso M, McClaren M. Calcium hydroxylate (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results. Aesthetic Surg J. 2010;30:235-238.
4. Moers-Carpi M, Tufet JO. Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: a 12-month, multicenter, prospective, randomized, controlled split-face trial. Dermatol Surg. 2008;34:210-215.